Select Page

TRODELVY ™ (sacituzumab govitecan-hziy) for injection, for intravenous use Initial U.S. Approval: 2020.

TRODELVY ™ (sacituzumab govitecan-hziy) for injection, for intravenous use Initial U.S. Approval: 2020.

TRODELVY is a prescription medicine. TRODELVY is used to treat triple-negative breast cancer.

INDICATIONS AND USAGE
TRODELVY is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.
This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for thisindication may be contingent upon verification and description of clinical benefit in confirmatory trials.
DOSAGE FORMS & STRENGTHS
For injection: 180 mg lyophilized powder in single-dose vials for econstitution.
Manufactured By: Immunomedics, Inc
Prescribing Information URL: Click Here

Procedure to buy TRODELVY ™ (sacituzumab govitecan-hziy) for injection?
To buy TRODELVY ™ (sacituzumab govitecan-hziy) for injection, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Sacituzumab govitecan, sold under the brand name Trodelvy, is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate for the treatment of adults with triple-negative breast cancer (TNBC) that has spread to other parts of the body and have received at least two prior therapies.

Sacituzumab govitecan has a boxed warning about the risk of severe neutropenia (abnormally low levels of white blood cells) and severe diarrhea. Sacituzumab govitecan may cause harm to a developing fetus or newborn baby.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

TRODELVY ™ (sacituzumab govitecan-hziy) for injection, in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
TRODELVY ™ (sacituzumab govitecan-hziy) for injection, in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
TRODELVY ™ (sacituzumab govitecan-hziy) for injection, in North America – Mexico.
TRODELVY ™ (sacituzumab govitecan-hziy) for injection, in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
TRODELVY ™ (sacituzumab govitecan-hziy) for injection, in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
TRODELVY ™ (sacituzumab govitecan-hziy) for injection, in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
TRODELVY ™ (sacituzumab govitecan-hziy) for injection, in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
TRODELVY ™ (sacituzumab govitecan-hziy) for injection, in Australia and New Zealand.

For Indian Patient

Ani-Cancer TRODELVY ™ (sacituzumab govitecan-hziy) for injection, are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

TRODELVY ™ (sacituzumab govitecan-hziy) for injection, can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “TRODELVY ™ (sacituzumab govitecan-hziy) for injection, for intravenous use Initial U.S. Approval: 2020.”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.